At baseline, patients with previous CD were, amongst others, younger, more often female and had more often a history of osteopenia or osteoporosis, whereas patients with previous acromegaly had a longer duration between tumor treatment and start of adult GH replacement therapy and were more often treated with radiotherapy. This evidence concerns the gene GH1 and osteoporosis.